Challenges and Solutions in Pharmaceutical Measurement Processes

Pharma manufacturing is complex and sometimes hazardous industry. The manufacturing process demands precise, safe and hygienic lifting at the weighing, processing and packaging stages. Our customized lifting solutions can address the main challenges in the industry like improving productivity plus large health and safety benefits.

The main challenges of pharma industry

The pharma manufacturing process involves much more than simply combining ingredients to form tablets, capsules, solutions or ointments. The process is heavily dependent on the material flowrate. High performance depends on consistently feeding substances into successive processes along the line, demanding reliability, accuracy, hygiene, and minimal interruptions.

The process is also hazardous. There are moving machine parts, pressurized equipment, and the manual handling of heavy materials, often in confined spaces. The lifting, pushing, pulling, carrying and putting down objects are currently responsible for an extraordinary 66% of accidents and injuries in the pharmaceutical industry.

Meanwhile, production managers face a relentless focus on productivity. Pharmacy has a long way to go to match other industries’ progress in rethinking how they operate to cut costs and contain staffing levels. Regardless of the subsector: big pharmacy, smaller companies, healthcare conglomerates and generics manufacturers may have different cost structures, but all have struggled to drive step-change productivity gains.

The weighroom is an important entry point into pharmaceutical manufacturing, with strict requirements on cleanliness. It is the transition point for materials coming from the warehouse and entering the processing area. The handling of substances in the weighroom is crucial. Careful attention to layout, equipment and operations here are the starting point for an efficient manufacturing process.

Weighroom design and equipment differ depending on the type of processing that takes place, but some common principles should drive the design of any pharmaceutical weighroom: a unidirectional flow of materials and personnel, segregation between hazardous and non-hazardous materials, and separation of storage and manufacturing items and spaces.

The current pharmaceutical environment has numerous significant drawbacks in the relationship between customers, pharmacists, and pharmaceutical firms. These challenges are mostly caused by the system’s fragmentation, which is characterized by separate components running on a variety of applications and software platforms. This fragmentation impedes the effective flow of information and monitoring throughout the medical system, resulting in a slew of issues. One notable disadvantage is the increase in unlawful transactions and prescription abuse. The absence of smooth communication among stakeholders allows for the sale of illegal drugs and inaccurate pharmaceutical delivery, causing major health hazards to consumers. These issues have not just health consequences, but also significant economic and healthcare ramifications, resulting in higher expenses and impaired patient safety. Furthermore, the lack of extensive data collection integrating systems makes reliable market demand analysis, detection of counterfeit products, comparison of patients’ medical histories, and validation of medical costs challenging. Inefficiencies and mistakes in the pharmaceutical supply chain are exacerbated by a lack of openness and real-time data exchange. In response to these issues, there is an urgent need for creative solutions that create a direct and secure link between customers, pharmacists, and pharmaceutical companies. Such solutions are intended to improve transparency, streamline processes, and ensure that patients receive safe and effective medication while combatting the black market and illegal drug trade. Finally, fixing these shortcomings in the pharmaceutical industry is critical for promoting a more economically and socially healthy healthcare system. Keywords: System’s fragmentation, software platforms, unlawful transactions, counterfeit products, pharmaceutical supply chain.

Sources: GLOBAL RESEARCH ONLINE.NET

TAWI.COM

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top